American Regent, Inc. Tech Stack

Sterile injectable manufacturer serving US and Canadian healthcare

Pharmaceutical Manufacturing Shirley, New York 501–1,000 employees Privately Held

American Regent manufactures sterile injectables for hospitals and clinics across North America as part of the Daiichi Sankyo Group. The tech stack—HPLC, Veeva Vault, SCADA, Allen-Bradley PLCs, and AS/400—reflects a highly regulated manufacturing operation with deep integration between lab analytics, document management, and plant-floor automation. Hiring is accelerating across manufacturing (22 roles) and sales (6), with active projects around facility expansion and inventory system integration, suggesting near-term capacity buildout.

Tech Stack 12 technologies

Core StackAllen-Bradley HPLC GCP AS/400 Veeva Siemens PLC Veeva Vault HMI SCADA CRM Labware LIMS PLM

What American Regent, Inc. Is Building

◆Challenges

Ensuring cgmp compliance
Competitive pricing and distribution
Optimizing supply chain cost
Managing manufacturing risk
Compliance with gmp regulations
Regulatory inspection readiness
Data integrity documentation
Reducing total cost of ownership
Ensuring supply continuity
Improving margin performance

▲Active Projects

Facility expansions
Annual territory sales plan
Integration of inventory into warehouse mobility system
Ds global procurement initiatives
Procurement governance frameworks
Account level business plans for idns
New product and line extension launches with idns
Contracting opportunities execution
Capital projects and equipment implementation
Pgc and pmr review

Hiring Activity

Accelerating40 roles · 40 in 30d

Department

Manufacturing

Sales

Logistics

Quality

Research

Security

Engineering

Healthcare

Seniority

Junior

Mid

Senior

Manager

Director

Notable leadership hires: Procurement Director, Quality Affairs Director

Company intelligence

Find more companies like American Regent, Inc. by tech stack, pain points and active projects

Get started free

About American Regent, Inc.

American Regent develops and manufactures sterile injectable pharmaceuticals—both branded and generic specialty products—for distribution to healthcare providers, clinics, and hospitals throughout the United States and Canada. The company operates manufacturing sites in New York, Ohio, and Pennsylvania with nationwide sales coverage. As a Daiichi Sankyo subsidiary, American Regent is investing significantly in modernization and expansion of its U.S. manufacturing footprint. The portfolio spans contract manufacturing, clinical research support, and R&D capabilities alongside animal health injectables.

HeadquartersShirley, New York

Company Size501–1,000 employees

Hiring MarketsUnited States

Frequently Asked Questions

What is American Regent's manufacturing footprint?

American Regent operates manufacturing locations in New York, Ohio, and Pennsylvania with sales territories covering the United States and Canada. The company is currently investing in modernization and expansion of its U.S. sites.

What tech does American Regent use in manufacturing?

American Regent's stack includes HPLC for analytics, Veeva Vault for document management, SCADA and Allen-Bradley PLCs for plant automation, Labware LIMS for lab workflows, and AS/400 for enterprise systems.

How this profile is built

American Regent, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.